טוען...
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
Neuromyelitis optica (NMO) is an autoimmune inflammatory disease of the central nervous system with preferential involvement in the optic nerve and spinal cord with a widespread spectrum of clinical features; multiple therapeutic agents have been used with different results. Recent evidence points t...
שמור ב:
| הוצא לאור ב: | J Res Med Sci |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367207/ https://ncbi.nlm.nih.gov/pubmed/28458709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-1995.200275 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|